Search Results for: DVA
By Chad Brand of Peridot CapitalistWhen I wrote about the Merck (MRK) deal to acquire Sirna Therapeutics (RNAI) on 10/31 and predicted more biotech deals were coming, I didn’t realize it would...
Published:
The FOMC did just come out and issue its discount on interest rates today. We saw a 0.25% RATE CUT FED FUNDS and we saw a 0.25% RATE CUT ON THE DISCOUNT RATE. That 0.25% dual cut...
Published:
Last Updated:
Usually you would think that a 400 point drop or a 500 point drop in the DJIA (NYSE: DIA) implies that capitulation is upon us. Right now, the word “hopefully” comes to mind as the greatest...
Published:
Last Updated:
Applied DNA Sciences is the newest company to see a big boost riding the coronavirus wave. In a sense, the company is getting into the vaccine business.
Published:
Swiss drug company Roche is trying to steal the part of biotech company Genentech (DNA) that it does not already own. Roche has offered to buy the 45% of DNA that belongs to public shareholders for...
Published:
Last Updated:
Engadget reports that Sony (SNE) is declaring victory in the war between the new Blu-Ray and HD DVD. Sony claims that disk sales for its Blu-Ray platform were 2-to-1 better than the competing format....
Published:
On Wednesday, we’ll get to see earnings out of Biogen Idec Inc. (NASDAQ: BIIB). The estimates from First Call for the biotech company are $0.80 EPS on $835.16 million in revenues. Estimates...
Published:
Last Updated:
Genentech (DNA) announced that a new study uncovered that fact that its Avastin cancer drug can improve survival among people with severe lung cancer when it is added to other treatments. It is good...
Published:
The board of Genentech (DNA) turned down an $86.50 offer by Roche to buy the part of the company that it does not already own. Until about a month ago, the offer had been higher–$89. Take This...
Published:
Last Updated:
These are some of this morning’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday: Cerner Corp. (NASDAQ: CERN) Raised to Overweight at...
Published:
Last Updated:
The hope for a higher Genentech Inc. (NYSE: DNA) buyout price is getting smaller and smaller. After the companies agreed to a $95.00 per share merger, this was already assumed as the nearly certain...
Published:
Last Updated:
From Investment Intelligencer In this summary paper, Dimensional Fund Advisors’s James Davis reviews the academic research on equity mutual-fund performance from 1969 to 2001. With some minor...
Published:
Last Updated:
Netflix (NASDAQ: NFLX) will not admit publicly that its DVD-via-mail business is dying. But, its announcement today that it will offer an “internet only” product is a powerful hint that the...
Published:
Last Updated:
Microsoft (NASDAQ: MSFT) backed the wrong horse in the fight for high definition DVD disks and players. Redmond sided with Toshiba and its HD DVD platform and shipped the Xbox 360 with playback...
Published: